Andres MI, et al. Biochemical effects of chlorpromazine on mouse neuroblastoma cells. Vet Hum Toxicol. 1999 Oct;41(5):273-8.
[Related articles] |
Ben Arush MW, et al. Neuroblastoma maturation by [(131)I] metaiodobenzylguanidine in chemoresistant neuroblastoma. Med Pediatr Oncol. 1999 Oct;33(4):418-9.
[Related articles] |
Bernardini S, et al. Modulation of glutathione transferase P1-1 activity by retinoic acid in neuroblastoma cells. J Cell Biochem. 1999 Dec 1;75(3):375-381.
[Related articles] |
Carlson K, et al. Organophosphorus compound-induced modification of SH-SY5Y human neuroblastoma mitochondrial transmembrane potential. Toxicol Appl Pharmacol. 1999 Oct 1;160(1):33-42.
[Related articles] |
Cattaneo MG, et al. Somatostatin inhibits PDGF-stimulated ras activation in human neuroblastoma cells. FEBS Lett. 1999 Oct 1;459(1):64-8.
[Related articles] |
Cinatl J Jr, et al. Bovine seminal ribonuclease selectively kills human multidrug-resistant neuroblastoma cells via induction of apoptosis. Int J Oncol. 1999 Nov;15(5):1001-1009.
[Related articles] |
De Moerloose B, et al. Discrepant flow cytometric expression and function of P-glycoprotein in neuroblastic tumors. Cytometry. 1999 Oct 1;37(2):125-32.
[Related articles] |
Elmlinger MW, et al. Correlation of type I insulin-like growth factor receptor (IGF-I-R) and insulin receptor-related receptor (IRR) messenger RNA levels in tumor cell lines from pediatric tumors of neuronal origin. Regul Pept. 1999 Oct 22;84(1-3):37-42.
[Related articles] |
Encinas M, et al. Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y. J Neurochem. 1999 Oct;73(4):1409-21.
[Related articles] |
Feng Z, et al. NF-kappaB/Rel proteins are required for neuronal differentiation of SH-SY5Y neuroblastoma cells. J Biol Chem. 1999 Oct 22;274(43):30341-4.
[Related articles] |
Forgeur A, et al. Natriuretic Peptide Receptors of Type A in Human Neuroblastomas. Neuroendocrinology. 1999 Oct;70(4):288-294.
[Related articles] |
Guidarelli A, et al. Different signalling pathways mediate the opposite effects of endogenous versus exogenous nitric oxide on hydroperoxide toxicity in CHP100 neuroblastoma cells. J Neurochem. 1999 Oct;73(4):1667-73.
[Related articles] |
Keren O, et al. Potentiation of transmitter release from NMB human neuroblastoma cells by kappa-opioids is mediated by N-type voltage-dependent calcium channels. Brain Res. 1999 Oct 2;843(1-2):193-198.
[Related articles] |
Kim CJ, et al. Up-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cells. Am J Pathol. 1999 Nov;155(5):1661-70.
[Related articles] |
Lindahl LS, et al. Differential ability of astroglia and neuronal cells to accumulate lead: dependence on cell type and on degree of differentiation. Toxicol Sci. 1999; 50(2):236-43.
[Related articles] |
Matsui T, et al. Induction of catecholamine synthesis in human neuroblastoma cells by replication inhibitors and sodium butyrate. Brain Res. 1999 Oct 2;843(1-2):112-117.
[Related articles] |
Pacheco MA, et al. Modulation of carbachol-stimulated AP-1 DNA binding activity by therapeutic agents for bipolar disorder in human neuroblastoma SH-SY5Y cells. Brain Res Mol Brain Res. 1999 Oct 1;72(2):138-46.
[Related articles] |
Pignatelli M, et al. Involvement of the NGFI-A gene in the differentiation of neuroblastoma cells. FEBS Lett. 1999 Nov 12;461(1-2):37-42.
[Related articles] |
Puyo AM, et al. Increased plasma atrial natriuretic factor in catecholamine-producing tumor patients. Clin Exp Hypertens. 1999 Oct;21(7):1129-44.
[Related articles] |
Raggi CC, et al. Real-time quantitative PCR for the measurement of MYCN amplification in human neuroblastoma with the TaqMan detection system. Clin Chem. 1999 Nov;45(11):1918-24.
[Related articles] MYCN Amplification
|
Schumann G, et al. Interleukin-6 activates signal transducer and activator of transcription and mitogen-activated protein kinase signal transduction pathways and induces de novo protein synthesis in human neuronal cells. J Neurochem. 1999 Nov;73(5):2009-17.
[Related articles] |
Spampinato S, et al. Characterization of a putative calcitonin receptor in IMR 32 human neuroblastoma cells. Neurosci Lett. 1999 Oct 8;273(3):167-70.
[Related articles] |
Tieu K, et al. Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: Involvement of Bcl-2 and p53 proteins. J Neurosci Res. 1999 Nov 1;58(3):426-435.
[Related articles] |
Tullio RD, et al. Changes in intracellular localization of calpastatin during calpain activation. Biochem J. 1999 Oct 15;343(Pt 2):467-472.
[Related articles] |
Yoshida H, et al. Induced immunity by expression of interleukin-2 or GM-CSF gene in murine neuroblastoma cells can generate antitumor response to established tumors. Cancer Gene Ther. 1999 Sep-Oct;6(5):395-401.
[Related articles] |
Young KW, et al. Lysophosphatidic acid-mediated Ca2+ mobilization in human SH-SY5Y neuroblastoma cells is independent of phosphoinositide signalling, but dependent on sphingosine kinase activation. Biochem J. 1999 Oct 1;343(Pt 1):45-52.
[Related articles] |